Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Diab

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancers|July 15, 2026
Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms TumorHadeel Halalsheh, Lana Amer, Mohammad Alzoubi, et al.
Journal of Pediatric Hematology/Oncology|September 9, 2025
Rhabdomyosarcoma in Pediatric Patients Under 2 Years: Clinical Features and OutcomeMohammad Alzoubi, Adam Diab, Nada Odeh, et al.
Cancers|May 27, 2026
Utilizing [<sup>18</sup>F]-FDG PET/CT Imaging for Enhanced Staging and Treatment Decisions in Pediatric RhabdomyosarcomaHadeel Halalsheh, Nada Odeh, Arwa Kiswani, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancers|July 15, 2026
Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms TumorHadeel Halalsheh, Lana Amer, Mohammad Alzoubi, et al.
Journal of Pediatric Hematology/Oncology|September 9, 2025
Rhabdomyosarcoma in Pediatric Patients Under 2 Years: Clinical Features and OutcomeMohammad Alzoubi, Adam Diab, Nada Odeh, et al.
Cancers|May 27, 2026
Utilizing [<sup>18</sup>F]-FDG PET/CT Imaging for Enhanced Staging and Treatment Decisions in Pediatric RhabdomyosarcomaHadeel Halalsheh, Nada Odeh, Arwa Kiswani, et al.
Pageof 1